한빛사296건

• • 정이든(경희대학교)

  • 이경민(경희대학교)

  • 이하연(경희대학교)

  • 연동건(경희대학교 의과대학, 경희의료원)

  Global burden of vaccine-associated angioedema and their related vaccines, 1967?2023: Findings from the global pharmacovigilance database

  • Allergy 2024 Aug 30 | https://doi.org/10.1111/all.16304

  • 2024.08
  • 바이오·의료융합

• • 이평세(Harvard Medical School / UC Berkeley)

  Nanoplasmonic biosensors for environmental sustainability and human health

  • Chem. Soc. Rev. Aug 28 2024, | https://doi.org/10.1039/d3cs00941f

  • 2024.08
  • 바이오·의료융합

• • Panchanathan Manivasagan(국립금오공과대학교)

  • 장의순(국립금오공과대학교)

  Progress in nanomaterial-based synergistic photothermal-enhanced chemodynamic therapy in combating bacterial infections

  • Prog. Mater. Sci. Volume 144 , August 2024, 101292 | https://doi.org/10.1016/j.pmatsci.2024.101292

  • 2024.08
  • 바이오·의료융합

• • 이종환(UC Berkeley, 한국화학연구원)

  • 송지환(한밭대학교)

  • 이평세(Harvard Medical School / UC Berkeley)

  Nanoplasmonic Rapid Antimicrobial-Resistance Point-of-Care Identification Device: RAPIDx

  • Adv. Healthc. Mater. 29 August 2024 | https://doi.org/10.1002/adhm.202402044

  • 2024.08
  • 바이오·의료융합

• • 서유리(충남대학교 분석과학기술대학원)

  • 장예진(한국화학연구원)

  • 이선경(기초과학연구원, 현 카스큐어 테라퓨틱스)

  • 김미현(한국화학연구원)

  • 이주용(충남대학교 분석과학기술대학원)

  • 명경재(기초과학연구원)

  A dual inhibitor of PIP5K1C and PIKfyve prevents SARS-CoV-2 entry into cells

  • Exp. Mol. Med. 01 August 2024 | https://doi.org/10.1038/s12276-024-01283-2

  • 2024.08
• 

  성예원

  NIH

  We study cisplatin, which is a widely used and effective anticancer drug, but it has significant side effects, including ototoxicity (hearing loss) and nephrotoxicity (kidney injury), in pediatric and adult cancer patients. In this paper, we investigated the role of macrophages in cisplatin-induced hearing loss and kidney injury in mice.

  • Sci. Adv.
  • 2024.08.21
• 

  Mahpara Safdar

  전남대학교

  This study presents the development and application of biocompatible gelatin nanoparticles (GNPs) as an innovative solution to enhance the delivery and effectiveness of agrochemicals in agriculture, aiming for more sustainable farming practices. The GNPs, which are approximately 150 nm in size with a positively charged surface (~30 mV), were specifically engineered to overcome the limitations associated with conventional pesticide applications, such as rapid degradation and environmental contamination.

  • Small
  • 2024.08.21

• • 양지명(울산대학교 의과대학, 서울아산병원)

  • 정세용(연세대학교 의과대학 )

  • 연동건(경희대학교 의과대학, 경희의료원)

  • 신재일(연세대학교 의과대학)

  • 이주용(울산대학교 의과대학, 서울아산병원)

  Cardiovascular and cerebrovascular adverse events associated with intravitreal anti-vascular endothelial growth factor monoclonal antibodies: a World

  • Ophthalmology July 12, 2024 | https://doi.org/10.1016/j.ophtha.2024.07.008

  • 2024.07
  • 의약학

• • 김인기(성균관대학교)

  • 김홍윤(POSTECH)

  • 고명철(POSTECH)

  • 김진곤(POSTECH)

  • 노준석(POSTECH)

  • 이평세(Harvard Medical School / UC Berkeley)

  Ultrafast Metaphotonic PCR Chip with Near-Perfect Absorber

  • Adv. Mater. Jul 31 2024, | https://doi.org/10.1002/adma.202311931

  • 2024.07
  • 바이오·의료융합

• • Uttam Ojha(경북대학교 약학대학)

  • 이유미(경북대학교 약학대학)

  Endothelial RUNX3 controls LSEC dysfunction and angiocrine LRG1 signaling to prevent liver fibrosis

  • Hepatology Jul 23 2024, | https://doi.org/10.1097/HEP.0000000000001018

  • 2024.07
  • 생명과학

• • Pantu Kumar Roy(경상국립대학교)

  • 박신영(경상국립대학교, Oregon State University)

  Comprehensive analysis of predominant pathogenic bacteria and viruses in seafood products

  • Compr. Rev. Food. Sci. Food Saf. Jul 2024, 23 (4) | https://doi.org/10.1111/1541-4337.13410

  • 2024.07
• 

  Javeria Zaheer

  한국원자력의학원

  Microplastics (MPs) are tiny particles (

  • J. Hazard. Mater.
  • 2024.07.29

• • 이수지(경희대학교)

  • 조혜수(경희대학교)

  • 이하연(경희대학교)

  • 박재유(경희대학교)

  • 우세린(경희대학교)

  • 연동건(경희대학교 의과대학, 경희의료원)

  Global estimates on the reports of vaccine-associated myocarditis and pericarditis from 1969 to 2023: Findings with critical reanalysis from the WHO p

  • J. Med. Virol. Jun 2024, 96 (6) | https://doi.org/10.1002/jmv.29693

  • 2024.06
  • 바이오·의료융합

• • 정이든(경희대학교)

  • 이경민(경희대학교)

  • 이수지(경희대학교)

  • 여승근(경희대학교)

  • 이하연(경희대학교)

  • 연동건(경희대학교 의과대학, 경희의료원)

  Global and regional burden of vaccine-associated facial paralysis, 1967-2023: Findings from the WHO international pharmacovigilance database

  • J. Med. Virol. Jun 2024, 96 (6) | https://doi.org/10.1002/jmv.29682

  • 2024.06
  • 바이오·의료융합

• • 조건호(인하대학교)

  • 전태준(인하대학교)

  • 김선민(인하대학교)

  Nanopore Detection of Sub-Nanosized Plastics in PE-Coated Paper Cups and Analysis of their Inflammatory Responses

  • Chem. Eng. J. Available online 22 June 2024 | https://doi.org/10.1016/j.cej.2024.153407

  • 2024.06
  • 바이오·의료융합

• • LingYue Shan(강원대학교)

  • 오덕환(강원대학교)

  Unraveling the gut microbiota‘s role in Rheumatoid arthritis: dietary pathways to modulation and therapeutic potential

  • Crit. Rev. Food Sci. Nutr. Jun 04 2024, | https://doi.org/10.1080/10408398.2024.2362412

  • 2024.06
  • 생명과학

• • 송록(국제백신연구소)

  Safety and immunogenicity of the Euvichol-S oral cholera vaccine for prevention of Vibrio cholerae O1 infection in Nepal: an observer-blind, active-co

  • Lancet Glob. Health May 2024, 12 (5) S2214-109X(24)00059-7 | https://doi.org/10.1016/S2214-109X(24)00059-7

  • 2024.05
  • 바이오·의료융합

• • 임재우(한국생명공학연구원, 오송첨단의료산업진흥재단)

  • 김은정(인천대학교)

  • 임은경(한국생명공학연구원)

  Dual structure-switching aptamer-mediated signal amplification cascade for SARS-CoV-2 detection

  • Biosens. Bioelectron. May 09 2024, 259 S0956-5663(24)00380-4 | https://doi.org/10.1016/j.bios.2024.116375

  • 2024.05
  • 바이오·의료융합
• 

  김성민

  Harvard University

  본 연구는 제가 속한 하버드대 그룹과 빌게이츠 재단의 공동연구로 이뤄졌으며, Sulfadoxine-pyrimethamine이라는 항말리아제를 투여 받은 산모들 (아프리카와 같은 개발도상국 지역)에게서 출산 체중 증가와 산모의 건강증진이라는 효과를 우연히 발견하게 되면서, 잘 알려지지 않은 기존 약물들의 숨겨진 효능을 밝히고자 연구를 시작하게 되었습니다.

  • EBioMedicine
  • 2024.05.02

• • 우호걸(경희대학교)

  • 김현진(경희대학교)

  • 박재유(경희대학교)

  • 여승근(경희대학교)

  • 연동건(경희대학교 의과대학, 경희의료원)

  Global burden of vaccine-associated multiple sclerosis, 1967-2022: A comprehensive analysis of the international pharmacovigilance database

  • J. Med. Virol. Apr 2024, 96 (4) | https://doi.org/10.1002/jmv.29591

  • 2024.04
  • 바이오·의료융합